rs749124658
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001195518.2(MICU1):c.40delG(p.Ala14LeufsTer20) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000664 in 1,612,430 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001195518.2 frameshift
Scores
Clinical Significance
Conservation
Publications
- proximal myopathy with extrapyramidal signsInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001195518.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MICU1 | NM_001195518.2 | MANE Select | c.40delG | p.Ala14LeufsTer20 | frameshift | Exon 2 of 12 | NP_001182447.1 | ||
| MICU1 | NM_001441218.1 | c.40delG | p.Ala14LeufsTer20 | frameshift | Exon 2 of 13 | NP_001428147.1 | |||
| MICU1 | NM_001441219.1 | c.40delG | p.Ala14LeufsTer20 | frameshift | Exon 2 of 13 | NP_001428148.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MICU1 | ENST00000361114.10 | TSL:1 MANE Select | c.40delG | p.Ala14LeufsTer20 | frameshift | Exon 2 of 12 | ENSP00000354415.5 | ||
| MICU1 | ENST00000642044.1 | c.40delG | p.Ala14LeufsTer20 | frameshift | Exon 2 of 14 | ENSP00000493232.1 | |||
| MICU1 | ENST00000635239.1 | TSL:5 | c.40delG | p.Ala14LeufsTer20 | frameshift | Exon 2 of 13 | ENSP00000489563.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152094Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000163 AC: 4AN: 246022 AF XY: 0.00000750 show subpopulations
GnomAD4 exome AF: 0.0000678 AC: 99AN: 1460336Hom.: 0 Cov.: 31 AF XY: 0.0000564 AC XY: 41AN XY: 726346 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152094Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74282 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Proximal myopathy with extrapyramidal signs Pathogenic:3
Intellectual disability, mild; pyramidal syndrome; dystonia; myoclonus; sensitivo-motor axonal neuropathy; hypotonia; intestinal malrotation
Variant summary: CBARA1 (MICU1) c.40delG (p.Ala14LeufsX20) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic in ClinVar (e.g. c.355C>T (p.Arg119*), c.547C>T (p.Gln183*))The variant allele was found at a frequency of 2.5e-05 in 277426 control chromosomes (gnomAD). c.40delG has been reported in the literature in at least one compound heterozygous individual affected with Myopathy With Extrapyramidal Signs (e.g. Cherot_2017). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two submitters have provided clinical-significance assessments for this variant to ClinVar after 2014 and both classified the variant as pathogenic (n=1) or likely pathogenic (n=1). Based on the evidence outlined above, the variant was classified as likely pathogenic.
not provided Pathogenic:2
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 33969448, 28708303)
This sequence change creates a premature translational stop signal (p.Ala14Leufs*20) in the MICU1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MICU1 are known to be pathogenic (PMID: 24336167). This variant is present in population databases (rs749124658, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with a neurodevelopmental disorder (PMID: 28708303). ClinVar contains an entry for this variant (Variation ID: 431146). For these reasons, this variant has been classified as Pathogenic.
Inborn genetic diseases Pathogenic:1
Neurodevelopmental disorder Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at